nafazatrom has been researched along with Adenocarcinoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ambrus, CM; Ambrus, JL; Gastpar, H; Williams, P | 1 |
| Haas, CD; Haas, JS; Kyle, GW | 1 |
| Crissman, JD; Haas, CD; Kyle, GW; Schaldenbrand, MF | 1 |
3 other study(ies) available for nafazatrom and Adenocarcinoma
| Article | Year |
|---|---|
Study of platelet aggregation in vivo. IX. Effect of nafazatrom on in vivo platelet aggregation and spontaneous tumor metastasis.
Topics: Adenocarcinoma; Animals; Breast Neoplasms; Carcinoma, Ehrlich Tumor; Female; Fibrinolytic Agents; Kidney Neoplasms; Lung Neoplasms; Macaca; Male; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Neoplastic Cells, Circulating; Neuroblastoma; Platelet Aggregation; Pyrazoles; Pyrazolones; Rats; Wilms Tumor | 1982 |
Nafazatrom: in-vitro assessment of radiation and drug activity against animal and human cell lines.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Line; Combined Modality Therapy; Female; Humans; Melanoma; Mice; Neoplasms, Experimental; Pyrazoles; Pyrazolones; Uterine Neoplasms | 1984 |
Nafazatrom: clonogenic in-vitro assessment of activity against human malignancies.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Squamous Cell; Cells, Cultured; Colony-Forming Units Assay; Female; Humans; Male; Pyrazoles; Pyrazolones; Tumor Stem Cell Assay | 1984 |